[Clinical studies on cases of XXXX during pregnancy (author's transl)].

@entity1 @entity712 @entity5852 @entity20831 @entity1763 @entity299 @entity8956 @entity65 @entity1229
The long term follow up studies on cases of @entity65 during pregnancy or delivery were reviewed in 181 @entity1 administrated in our clinic. The results as follows: 1. An incidence of @entity1 with @entity65 during pregnancy was 1.46 per cent as a whole, and there was increasing tendency in @entity299 . 2. An @entity712 during pregnancy was seen in 7.7 per cent and all cases with NYHA III grade had an incidence of 100 per cent. 3. The occurrence of @entity8956 and @entity20831 pregnancy were more frequently seen in group of @entity299 than in controls. But, no difference was observed in spontaneous @entity1763 . 4. 28 @entity1 with Starr-Edwards prosthetic heart valves became pregnant in our clinic. In these pregnancies, 5 cases receiving with @entity1229 therapy resulted in 3 anomalies of new born and in 2 spontaneous @entity5852 . So, the use of @entity1229 seemed to have the risk to the fetus. But omission of the anticoagulant therapy on the other hand, increased the danger of systemic embolization to the mother. 5. The follow up study by mail in some cases revealed that, as a general, pregnancy and delivery may aggravate the condition of @entity1 , especially who had mitral @entity712 .
